Role of miR‐200 family members in survival of colorectal cancer patients treated with fluoropyrimidines

miR-200a, miR-200c, miR-141, and miR-429 expression levels may identify CRC patients, including those with stage II disease, who are most likely to benefit from adjuvant chemotherapy.